Written for dentists working in general, family and cosmetic dentistry, as well as specialists from all disciplines, Decisions in Dentistry is a peer-reviewed journal designed to support the highest standards of professionalism and integrity in multidisciplinary care. Reflecting the latest thinking from nationally ranked educators, researchers and clinicians, the journal presents evidence-based, clinically relevant articles in an inviting and easy-to-understand format. Unique in its approach, Decisions in Dentistry makes the complex simple and offers unbiased information and continuing education that dentists can use to improve their technique and provide the highest level of care.
The risk of COVID-19 transmission via dental aerosols is a conundrum faced by dental practices everywhere. The clinic at the University of Michigan (U-M) School of Dentistry in Ann Arbor is no exception. With 40 operatories separated by…
In January 2018, Tennessee’s Medicaid program, TennCare, changed its reimbursement policy regarding dental opioid prescriptions for patients age 20 and younger with significant results. New data demonstrate a 45% decrease in opioid…
Americans are doing what they can to save money in these unprecedented times, but there is one area where many are willing to pay more: the dental office. Specifically, patients would pay more for less painful dental injections.
Researchers from Harvard’s T.H. Chan School of Public Health suggest patients with periodontal disease may be at greater risk of developing cancer than the general population.
According to a recent poll from the American Dental Association Health Policy Institute, patients are open to the idea of routine vaccination at the dental office.
Although cigarette smoking has been on the decline for a decade, two trends have become popular with young adults between the ages of 18 and 25: electronic cigarettes and marijuana.
In a move heralding the first COVID-19 treatment to receive approval from the U.S. Food and Drug Administration (FDA), the antiviral drug remdesivir has been approved for treating patients hospitalized with COVID-19.